1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Oklahoma Center for Biomedical Research Excellence in Sensory Biology is sponsored by National Institutes of Health (NIH). This grant establishes a Center for Biomedical Research Excellence to serve as a hub for research into how cells sense and respond to their environment and the diseases that can occur when that process malfunctions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIH Awards OU College of Medicine $10. 7 Million to Advance Sensory Biology Research The University of Oklahoma NIH Awards OU College of Medicine $10. 7 Million to Advance Sensory Biology Research NIH Awards OU College of Medicine $10.
7 Million to Advance Sensory Biology Research OKLAHOMA CITY – The University of Oklahoma College of Medicine has been awarded a five-year, $10. 7 million grant from the National Institutes of Health to create the Oklahoma Center for Biomedical Research Excellence in Sensory Biology.
The center will serve as a hub for research into how cells sense and respond to their environment and the diseases that can occur when that process malfunctions. The highly competitive grant, from the National Institute of General Medical Sciences, is a COBRE (Centers of Biomedical Research Excellence) award.
Its primary goal is to strengthen biomedical research programs by expanding research infrastructure and supporting the careers of early-stage investigators in states that have historically received less NIH funding. Twenty-three states are eligible for this mechanism of support. Leonidas Tsiokas, Ph.
D. , professor and chair of the college’s Department of Cell Biology, will lead the work of the grant. Researchers will study how cells sense their environment by using laboratory models ranging from roundworms and algae to mice and human tissue.
A major focus will be on cilia – tiny, hair-like structures protruding from the cells that act like microscopic antennas, allowing cells to sense and receive important signals. Defects in cilia have been linked to nearly every organ in the body and more than 40 diseases, including polycystic kidney disease, congenital heart disease, obesity, scoliosis, neuronal malformations and some types of cancer.
“A lot of major diseases are associated with the well-being of that little hair-like structure,” Tsiokas said. “This is a relatively unexplored niche of research, and we’re proud to be at the forefront of it. ” The COBRE grant provides funding and mentorship to four junior researchers in the College of Medicine.
The researchers and their projects are: Lea Bennett, Ph. D. , Department of Ophthalmology, who studies mechanisms of retinal degeneration.
Julie Craft Van De Weghe, Ph. D. , Department of Cell Biology, who studies a neurodevelopmental condition called Joubert Syndrome.
Rosalia Paterno, M. D. , Department of Neurosurgery, who studies cilia dysfunction in neuropsychiatric disorders such as autism spectrum disorder, schizophrenia and bipolar disorder.
Xinxing Zhang, Ph. D. , Department of Cell Biology, who studies how cells detect and regulate copper.
The COBRE award will also fund two research equipment cores – shared research facilities that provide specialized technologies too expensive for individual laboratories to maintain on their own. The Super-Resolution Imaging Core will provide researchers with sophisticated imaging techniques to visualize cells that are just a few nanometers apart.
The Cell and Genetic Engineering Core will give researchers access to advanced tools to better understand how genes and proteins function in healthy cells and in disease. Tsiokas estimates that the Department of Cell Biology has the highest concentration of cilia researchers of any institution in the country. Only in the past 20 years has the scientific community realized the importance of cilia in human health and disease.
“Cilia throughout the body have their own ways of sensing and responding to their surroundings,” he said. “Every part of the body depends on these signaling systems to function properly. We plan to build on discoveries that have already been made and ultimately hope to uncover new biological mechanisms that could lead to better ways to prevent, diagnose and treat a wide range of illnesses.
” Research reported in this release was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number P20GM161969-01.
Additional support for the Oklahoma Center for Biomedical Research Excellence in Sensory Biology has been provided by the Office of the Provost on the OU Health Campus, the Dean’s Office in the OU College of Medicine, the Office of the Vice President for Research on the OU Health Campus, and the Department of Cell Biology. Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma.
As the state’s flagship university, OU serves the educational, cultural, economic and healthcare needs of the state, region and nation. For more information about the university, visit www. ou.
edu . Driving down the cost of self-driving cars In the Mobility Intelligence Lab at OU, Bin Xu and other researchers are developing a prototype autonomous driving system that can retrofit any consumer vehicle with about $1,000 worth of hardware.
Read article: Driving down the cost of self-driving cars Read article: Driving down the cost of self-driving cars Study Targets Prostate Cancer Screening Gap Among Black Men A newly funded study at the University of Oklahoma aims to increase prostate-specific antigen (PSA) screening among Black men in Oklahoma, who die from prostate cancer at rates two to four times higher than other racial groups.
An interactive app called Connect2Care may hold the key to early detection, which is crucial for improving survival.
Read article: Study Targets Prostate Cancer Screening Gap Among Black Men Read article: Study Targets Prostate Cancer Screening Gap Among Black Men OU team receives NSF award to support talented STEM students with financial need The U.S. National Science Foundation has awarded OU with a roughly $2 million grant to provide scholarships for undergraduate students pursuing engineering degrees.
The program is expected to support cohorts of students beginning in fall 2027. Read article: OU team receives NSF award to support talented STEM students with financial need Read article: OU team receives NSF award to support talented STEM students with financial need Updated 7/16/2026 by OU News : cmshelp@ou. edu
According to the current listing, eligibility includes: Universities, particularly those in IDeA states. Confirm the full requirements in the official notice before applying.
Oklahoma Center for Biomedical Research Excellence in Sensory Biology is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article